These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19361529)

  • 21. Clinical and virological survey of patients with hepatitis B surface antigen in an Italian region: clinical considerations and disease burden.
    Torre F; Basso M; Giannini EG; Feasi M; Boni S; Grasso A; De Leo P; Dodi F; Marazzi MG; Azzola E; Bartolacci V; Percario G; Beltrame A; Borro P; Picciotto A;
    J Med Virol; 2009 Nov; 81(11):1882-6. PubMed ID: 19774694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of acquiring hepatitis A virus disease in a large Italian region in endemic and epidemic periods.
    Lopalco PL; Malfait P; Menniti-Ippolito F; Prato R; Germinario C; Chironna M; Quarto M; Salmaso S
    J Viral Hepat; 2005 May; 12(3):315-21. PubMed ID: 15850473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatitis A in Poland in 2003].
    Magdzik W
    Przegl Epidemiol; 2005; 59(2):289-95. PubMed ID: 16190532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
    Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
    Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long term effectiveness of vaccination of Hepatitis A].
    Yao K; Yu FX; Li L; Feng H; Li H; Zhang XY; Yin F; Zhu CR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 43(2):200-5. PubMed ID: 22650031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Updated recommendations from the Advisory Committee on Immunization Practices (ACIP) for use of hepatitis A vaccine in close contacts of newly arriving international adoptees.
    ;
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(36):1006-7. PubMed ID: 19763077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination.
    Romanò L; Paladini S; Tagliacarne C; Zappa A; Zanetti AR
    Vaccine; 2009 May; 27(25-26):3439-42. PubMed ID: 19200848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of hepatocellular carcinoma through hepatitis B vaccination in areas of high endemicity: perspectives for global liver cancer prevention.
    Plymoth A; Viviani S; Hainaut P
    Cancer Lett; 2009 Dec; 286(1):15-21. PubMed ID: 19836128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of hepatitis A vaccination programs for migrant children on the incidence of hepatitis A in The Netherlands.
    Suijkerbuijk AW; Lindeboom R; van Steenbergen JE; Sonder GJ; Doorduyn Y
    Eur J Public Health; 2009 Jun; 19(3):240-4. PubMed ID: 19174503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes in endemicity of hepatitis A in Poland].
    Magdzik W; Czarkowski MP
    Przegl Epidemiol; 2004; 58(1):3-8. PubMed ID: 15218636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decline in the risk of hepatitis A virus infection in China, a country with booming economy and changing lifestyles.
    Xu ZY; Wang XY; Liu CQ; Li YT; Zhuang FC
    J Viral Hepat; 2008 Oct; 15 Suppl 2():33-7. PubMed ID: 18837831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A statistical model to estimate the impact of a hepatitis A vaccination programme.
    Oviedo M; Pilar Muñoz M; Domínguez A; Borras E; Carmona G
    Vaccine; 2008 Nov; 26(48):6157-64. PubMed ID: 18804511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measles serological survey in the Italian population: interpretation of results using mixture model.
    Rota MC; Massari M; Gabutti G; Guido M; De Donno A; Ciofi degli Atti ML
    Vaccine; 2008 Aug; 26(34):4403-9. PubMed ID: 18585420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis A infection in recent international adoptees and their contacts in Minnesota, 2007-2009.
    Sweet K; Sutherland W; Ehresmann K; Lynfield R
    Pediatrics; 2011 Aug; 128(2):e333-8. PubMed ID: 21727107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children.
    Al-Aziz AM; Awad MA
    East Mediterr Health J; 2008; 14(5):1028-35. PubMed ID: 19161074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing travel-related global epidemiology of hepatitis A.
    Steffen R
    Am J Med; 2005 Oct; 118 Suppl 10A():46S-49S. PubMed ID: 16271541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different transmission patterns of hepatitis A virus for two main risk groups as evidenced by molecular cluster analysis.
    Tjon G; Xiridou M; Coutinho R; Bruisten S
    J Med Virol; 2007 May; 79(5):488-94. PubMed ID: 17385681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality.
    Lehman EM; Wilson ML
    J Viral Hepat; 2009 Sep; 16(9):650-8. PubMed ID: 19413698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence of hepatitis B infection in the Turkish population in Northern Cyprus.
    Kurugöl Z; Koturoğlu G; Akşit S; Ozacar T; ; Kayimbaşoğlu S; Ozbalikçi S; Erçal G; Güllüelli E; Bakkaloğlu F; Doğan E; Garabli H; Erçal H; Mert C
    Turk J Pediatr; 2009; 51(2):120-6. PubMed ID: 19480322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.